Page last updated: 2024-08-16

temozolomide and mitoxantrone

temozolomide has been researched along with mitoxantrone in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bissola, L; Boiardi, A; Botturi, A; Broggi, G; Eoli, M; Finocchiaro, G; Lamperti, E; Salmaggi, A; Silvani, A1
Bartolomei, M; Boiardi, A; Botturi, A; Broggi, G; Eoli, M; Lamperti, E; Salmaggi, A; Silvani, A1
Boiardi, A; Botturi, A; Broggi, G; Di Meco, F; Eoli, M; Falcone, C; Filippini, G; Fiumani, A; Gaviani, P; Lamperti, E; Salmaggi, A; Silvani, A; Solari, A1
Bleau, AM; Brennan, CW; Fomchenko, EI; Hambardzumyan, D; Holland, EC; Huse, JT; Ozawa, T1
Bai, J; Fan, X; Hu, J; Hu, M; Ji, M; Jin, J; Li, Y; Sun, Y; Wang, B; Wang, X; Zhao, S1

Reviews

1 review(s) available for temozolomide and mitoxantrone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for temozolomide and mitoxantrone

ArticleYear
New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM).
    Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:4 Suppl

    Topics: Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Glioblastoma; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Pilot Projects; Polyethylene Glycols; Radioimmunotherapy; Temozolomide

2003

Other Studies

7 other study(ies) available for temozolomide and mitoxantrone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma.
    Journal of neuro-oncology, 2005, Volume: 75, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Dacarbazine; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Survival Analysis; Temozolomide; Time Factors; Tumor Burden

2005
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?
    Journal of neuro-oncology, 2008, Volume: 88, Issue:1

    Topics: Adult; Aged; Aging; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neurosurgical Procedures; Positron-Emission Tomography; Retrospective Studies; Survival; Temozolomide; Treatment Outcome

2008
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.
    Cell stem cell, 2009, Mar-06, Volume: 4, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Cells, Cultured; Chromones; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glioma; Humans; Mice; Mice, Nude; Mitoxantrone; Morpholines; Neoplasm Proteins; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Temozolomide

2009
Evaluation of inhibitory effects of flavonoids on breast cancer resistance protein (BCRP): From library screening to biological evaluation to structure-activity relationship.
    Toxicology in vitro : an international journal published in association with BIBRA, 2019, Volume: 61

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Cell Line; Cell Survival; Dogs; Doxorubicin; Flavonoids; Humans; Male; Mitoxantrone; Molecular Docking Simulation; Neoplasm Proteins; Rats, Sprague-Dawley; Structure-Activity Relationship; Temozolomide

2019